National Cancer Institute/National Institutes of Health

Bethesda, Maryland 20892

1 studies enrolling now · 5 studies all time

What they study most

Hippel-Lindau Disease, Kidney Cancer, Lymphoproliferative Disorders, Neurofibromatosis 1, Plexiform Neurofibroma, Quality of Life, Renal Cell Carcinoma

Studies at this site

• Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 — Recruiting now
• Exploring The Role Of Palliative Care In Phase 1 Enrolled Pediatric Oncology Patients — Stopped early
• Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma — Stopped early
• 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease — Completed
• Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease — Stopped early